Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2012, Article ID 746358, 9 pages
http://dx.doi.org/10.1155/2012/746358
Clinical Study

Pulmonary Bacterial Communities in Surgically Resected Noncystic Fibrosis Bronchiectasis Lungs Are Similar to Those in Cystic Fibrosis

1Centre for the Analysis of Genome Evolution & Function, University of Toronto, Toronto, ON, Canada M5S 3B2
2Department of Cell & Systems Biology, University of Toronto, Toronto, ON, Canada M5S 3G5
3Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada M5S 1A8
4Latner Thoracic Surgery Research Laboratories, University Health Network, Toronto, ON, Canada
5Division of Respirology, St. Michael’s Hospital and University of Toronto, Toronto, ON, Canada
6Department of Pathology, Toronto General Hospital, University Health Network, Room 11E423, 200 Elizabeth Street, Toronto, ON, Canada M5G 2C4

Received 15 July 2011; Accepted 27 October 2011

Academic Editor: Stefano Centanni

Copyright © 2012 Heather Maughan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. King, S. Holdsworth, N. Freezer, and P. Holmes, “Bronchiectasis,” Internal Medicine Journal, vol. 36, no. 11, pp. 729–737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. T. King, “The pathophysiology of bronchiectasis,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 4, pp. 411–419, 2009. View at Google Scholar · View at Scopus
  3. P. T. King, S. R. Holdsworth, N. J. Freezer, E. Villanueva, M. Gallagher, and P. W. Holmes, “Outcome in adult bronchiectasis,” Journal of Chronic Obstructive Pulmonary Disease, vol. 2, no. 1, pp. 27–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. T. King, S. R. Holdsworth, N. J. Freezer, E. Villanueva, and P. W. Holmes, “Microbiologic follow-up study in adult bronchiectasis,” Respiratory Medicine, vol. 101, no. 8, pp. 1633–1638, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Pasteur, S. M. Helliwell, S. J. Houghton et al., “An investigation into causative factors in patients with bronchiectasis,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1277–1284, 2000. View at Google Scholar · View at Scopus
  6. J. Angrill, C. Agustí, R. De Celis et al., “Bronchial inflammation and colonization in patients with clinically stable bronchiectasis,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 9, pp. 1628–1632, 2001. View at Google Scholar · View at Scopus
  7. J. Angrill, C. Agustí, R. De Celis et al., “Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors,” Thorax, vol. 57, no. 1, pp. 15–19, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. V. M. Möller, W. Timens, W. Van Der Bij et al., “Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 3, pp. 950–956, 1998. View at Google Scholar · View at Scopus
  9. H. Cabello, A. Torres, R. Celis et al., “Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study,” European Respiratory Journal, vol. 10, no. 5, pp. 1137–1144, 1997. View at Google Scholar · View at Scopus
  10. M. B. Nicotra, M. Rivera, A. M. Dale, R. Shepherd, and R. Carter, “Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort,” Chest, vol. 108, no. 4, pp. 955–961, 1995. View at Google Scholar · View at Scopus
  11. J. A. Pang, A. Cheng, H. S. Chan, and G. French, “The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage,” American Review of Respiratory Disease, vol. 139, no. 1, pp. 14–17, 1989. View at Google Scholar · View at Scopus
  12. R. L. Gibson, J. L. Burns, and B. W. Ramsey, “Pathophysiology and management of pulmonary infections in cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 8, pp. 918–951, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Hyde and H. Humphreys, “Absence of Burkholderia cepacia from the respiratory tract of non-cystic fibrosis patients,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 16, no. 3, pp. 253–254, 1997. View at Google Scholar · View at Scopus
  14. S. G. Tringe and E. M. Rubin, “Metagenomics: DNA sequencing of environmental samples,” Nature Reviews Genetics, vol. 6, no. 11, pp. 805–814, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. P. J. Turnbaugh, R. E. Ley, M. Hamady, C. M. Fraser-Liggett, R. Knight, and J. I. Gordon, “The human microbiome project,” Nature, vol. 449, no. 7164, pp. 804–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Mullard, “Microbiology: the inside story,” Nature, vol. 453, no. 7195, pp. 578–580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. G. B. Rogers, M. P. Carroll, D. J. Serisier et al., “Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis,” Journal of Clinical Microbiology, vol. 44, no. 7, pp. 2601–2604, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. G. B. Rogers, M. P. Carroll, D. J. Serisier et al., “Bacterial activity in cystic fibrosis lung infections,” Respiratory Research, vol. 6, article 49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. G. B. Rogers, M. P. Carroll, D. J. Serisier, P. M. Hockey, G. Jones, and K. D. Bruce, “Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling,” Journal of Clinical Microbiology, vol. 42, no. 11, pp. 5176–5183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. G. B. Rogers, C. A. Hart, J. R. Mason, M. Hughes, M. J. Walshaw, and K. D. Bruce, “Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling,” Journal of Clinical Microbiology, vol. 41, no. 8, pp. 3548–3558, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kolak, F. Karpati, H. J. Monstein, and J. Jonasson, “Molecular typing of the bacterial flora in sputum of cystic fibrosis patients,” International Journal of Medical Microbiology, vol. 293, no. 4, pp. 309–317, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. K. Harris, M. A. De Groote, S. D. Sagel et al., “Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 51, pp. 20529–20533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Bittar, H. Richet, J. C. Dubus et al., “Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients,” PLoS ONE, vol. 3, no. 8, article e2908, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. D. Sibley, M. D. Parkins, H. R. Rabin, K. Duan, J. C. Norgaard, and M. G. Surette, “A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 39, pp. 15070–15075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Doud, E. Zeng, L. Schneper, G. Narasimhan, and K. Mathee, “Approaches to analyse dynamic microbial communities such as those seen in cystic fibrosis lung,” Human Genomics, vol. 3, no. 3, pp. 246–256, 2009. View at Google Scholar · View at Scopus
  26. M. J. Cox, M. Allgaier, B. Taylor et al., “Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients,” PLoS ONE, vol. 5, no. 6, article e11044, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. Guss, G. Roeselers, I. L. G. Newton et al., “Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis,” ISME Journal, vol. 5, no. 1, pp. 20–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. F. Altschul, W. Gish, W. Miller, E. W. Myers, and D. J. Lipman, “Basic local alignment search tool,” Journal of Molecular Biology, vol. 215, no. 3, pp. 403–410, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. J. G. Caporaso, J. Kuczynski, J. Stombaugh et al., “QIIME allows analysis of high-throughput community sequencing data,” Nature Methods, vol. 7, no. 5, pp. 335–336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. Wang, G. M. Garrity, J. M. Tiedje, and J. R. Cole, “Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy,” Applied and Environmental Microbiology, vol. 73, no. 16, pp. 5261–5267, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Lozupone and R. Knight, “UniFrac: a new phylogenetic method for comparing microbial communities,” Applied and Environmental Microbiology, vol. 71, no. 12, pp. 8228–8235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. R Development Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2011.
  33. C. D. Sibley, K. Duan, C. Fischer et al., “Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections,” PLoS Pathogens, vol. 4, no. 10, Article ID e1000184, 2008. View at Publisher · View at Google Scholar · View at Scopus